文献速递心力衰竭与心肌病

围产期心肌病:从遗传学到管理

Peripartum cardiomyopathy: from genetics to management.
PubMed 文献 · Eur Heart J · 2021-01-01

围产期心肌病(PPCM)在全球所有种族中均有发生,妊娠晚期或产后数月出现心衰症状和体征且证实左心室功能障碍时应怀疑本病。应排除其他病因,紧急行心电图和利钠肽检测,异常者紧急转诊心内科;有心肌病或猝死家族史者考虑遗传学评估。母体死亡率0%至30%不等,略低于半数患者心肌恢复。

要点

  • 妊娠晚期或产后数月出现心衰症状和体征,应怀疑PPCM并证实左心室功能障碍。
  • 紧急行心电图和利钠肽检测,异常者紧急转诊心内科专家管理。
  • 有心肌病或猝死家族史者应考虑遗传学评估。

核心结论

  • PPCM在全球所有种族中均有发生,母体和新生儿发病率和死亡率显著。
  • 母体死亡率范围为0%至30%,取决于种族背景和地理区域。
  • 略低于半数女性经历心肌恢复。
  • 在发病机制理解及患者管理和治疗方面已取得显著进展。

研究设计与样本

  • 综述总结了PPCM的遗传学、病理生理学、诊断方法、管理和结局的当前知识。

主要发现

  • PPCM母体死亡率范围0%至30%,取决于种族背景和地理区域。
  • 略低于半数女性经历心肌恢复。

关键数值与推荐

  • 妊娠晚期或产后数月出现心衰症状和体征且证实左心室功能障碍时应怀疑PPCM。
  • 应排除其他病因,紧急行心电图和利钠肽检测(如可用)。
  • 超声心动图作为下一步检查。
  • 心脏检查异常者应紧急转诊心内科团队。
  • 有心肌病或猝死家族史者应考虑转诊进行遗传学评估。

临床怎么用

  • 对妊娠晚期或产后数月出现心衰症状和体征的围产期女性,应怀疑PPCM并评估左心室功能。
  • 紧急行心电图和利钠肽检测,异常者紧急转诊心内科。
  • 有心肌病或猝死家族史者考虑遗传学评估。

局限性

  • 本文为综述,未报告原始研究的设计细节和样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Peripartum cardiomyopathy (PPCM) is a disease that occurs globally in all ethnic groups and should be suspected in any peripartum women presenting with symptoms and signs of heart failure, towards the end of pregnancy or in the months following delivery, with confirmed left ventricular dysfunction. After good history taking, all women should be thoroughly assessed, and alternative causes should be excluded. Urgent cardiac investigations with electrocardiogram and natriuretic peptide measurement (if available) should be performed. Echocardiography follows as the next step in investigation. Patients with abnormal cardiac investigations should be urgently referred to a cardiology team for expert management. Referral for genetic work-up should be considered if there is a family history of cardiomyopathy or sudden death. PPCM is a disease with substantial maternal and neonatal morbidity and mortality. Maternal mortality rates range widely, from 0% to 30%, depending on the ethnic background and geographic region. Just under half of women experience myocardial recovery. Remarkable advances in the comprehension of the pathogenesis and in patient management and therapy have been achieved, largely due to team efforts and close collaboration between basic scientists, cardiologists, intensive care specialists, and obstetricians. This review summarizes current knowledge of PPCM genetics, pathophysiology, diagnostic approach, management, and outcome.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Sliwa K, Bauersachs J, Arany Z, et al. Peripartum cardiomyopathy: from genetics to management. Eur Heart J. 2021. PMID: 34322694. doi:10.1093/eurheartj/ehab458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。